Author

B. Creyns

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

A. L. Coelho· 2 shared B. MacKenzie· 2 shared C. M. Hogaboam· 2 shared A. Guenther· 1 shared B. Windsor· 1 shared C. Ruppert· 1 shared D. Christensen· 1 shared K. Hoetzenecker· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. L. Coelho

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis

B. MacKenzie, P. Mahavadi, Y. A. P. Jannini-Sa, B. Creyns, A. L. Coelho, M. Espindola, C. Ruppert, K. Hoetzenecker, C. M. Hogaboam, A. Guenther

This study evaluates the anti-fibrotic effects of LTI-03 in IPF patient-derived precision cut lung slices, showing dose-dependent reduction of fibrotic markers.

bioRxiv · Apr 24, 2024 · PreprintPharmacology & Toxicology

Caveolin scaffolding domain (CSD) peptide LTI-2355 modulates the phagocytic and synthetic activity of lung derived myeloid cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-acute sequelae of COVID-fibrosis (PASC-F)

B. Creyns, B. MacKenzie, Y. Sa, A. L. Coelho, D. Christensen, T. Parimon, B. Windsor, C. M. Hogaboam

This study shows that the CSD peptide LTI-2355 improves phagocytic and reduces pro-inflammatory activity in myeloid cells from IPF and PASC-F patients.

bioRxiv · Dec 1, 2023Immunology